Consensus clinical management guideline for beta‐propeller protein‐associated neurodegeneration-Reference-Cited by-同舟云学术

Consensus clinical management guideline for beta‐propeller protein‐associated neurodegeneration

Published:2021-08-04 Issue:12 Volume:63 Page:1402-1409
ISSN:0012-1622
Container-title:Developmental Medicine & Child Neurology
language:en
Short-container-title:Dev Med Child Neurol

Author:

Wilson Jenny L¹^ORCID,Gregory Allison²,Kurian Manju A³^ORCID,Bushlin Ittai¹,Mochel Fanny⁴,Emrick Lisa⁵,Adang Laura⁶,Hogarth Penelope⁷^ORCID,Hayflick Susan J⁸^ORCID,Rogers Caleb,Lee Jae‐Hyeok,Burke Kimberly,Dyer Meg Tally,Stretter Donna,

Affiliation:

1. Division of Pediatric Neurology Oregon Health & Science University Portland ORUSA

2. Department of Molecular and Medical Genetics Oregon Health & Science University Portland OR USA

3. Molecular Neurosciences Developmental Neurosciences Programme UCL Institute of Child Health London UK

4. Department of Genetics Reference Center for Neurometabolic Diseases Assistance Publique–Hôpitaux de Paris University Hospital La Pitié Salpêtrière Paris France

5. Division of Neurology and Developmental Neuroscience Department of Pediatrics Department of Human and Molecular Genetics Baylor College of Medicine Houston TXUSA

6. Division of Neurology Children’s Hospital of Philadelphia Philadelphia PAUSA

7. Departments of Molecular and Medical Genetics and Neurology Oregon Health & Science University Portland ORUSA

8. Departments of Molecular and Medical Genetics, Pediatrics, and Neurology Oregon Health & Science University Portland OR USA

Publisher

Wiley

Subject

Clinical Neurology,Developmental Neuroscience,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dmcn.14980

Reference32 articles.

1. Exome Sequencing Reveals De Novo WDR45 Mutations Causing a Phenotypically Distinct, X-Linked Dominant Form of NBIA

2. Consensus clinical management guideline for pantothenate kinase-associated neurodegeneration (PKAN)